Lubango - Over USD 250 million have been invested over the last 25 years by US oil company Chevron in community projects in the areas of health, education, economic development and environmental impact studies in Angola.
The information was provided to the press Wednesday in Lubango, southern Huila Province, by the company´s managing director in Angola, Billy Lacobie, on the sidelines of the inauguration of the Irene Neto Maternity Hospital, as a result of one of the company's social responsibility activities.
Billy Lacobie noted that the company intends to continue making community investments in this respect, always in partnership with the national concessionaire, as its social investment programmes in Angola represent a long term commitment to the sustainable and continuous development of the communities in which it operats.
He said that Chevron has partnerships with government institutions, communities, development partners and non-governmental organisations for the identification, planning, execution, monitoring and evaluation of all the company's projects.
According to him, the US oil company has selected and supported strategic development in health, education and economic activity, as well as those related to the environment that make it possible to create sustainable businesses and social and economic values for the communities, which focus on the provinces of Cabinda, Luanda and Zaire.
According to Billy Lacobie, the oil company´s investment projects are intended to give priority to improving health conditions in communities, although he does not rule out partnerships with government, community, public and private institutions to improve access to health care and share knowledge to train local communities in order to fight and prevent infectious diseases.
Chevron managing director, revealed that over the years, the health projects of the company in Angola have made a significant contribution to the fight against malaria, Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency syndrome (AIDS), tuberculosis and sickle cell disease.
“Our efforts and partnerships have benefited over 204,000 people through our continued investment to reduce morbidity and mortality in the communities”, Billy Lacobie explained.
